Anxiety can lower our cognitive and creative abilities, and make us very uncomfortable. One aspect of it is negative self-evaluation, thinking that we did poorly at something.
It especially happens when having to be in social situations or when having to speak or perform before an audience. This 2011 study from Brazil found that 600 mg of CBD one to two hours before having to quickly create a speech then perform it will greatly reduce anxiety and improve performance, and reduce negative self-evaluation.
Anxious in front of people? Need peak performance while creating or performing in front of others, such as acting, speaking, dancing, or playing music? Then try 300-600 mg CBD with no THC.
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
Neuropsychopharmacology. 2011 May; 36(6): 1219–1226, doi: 10.1038/npp.2011.6
“The anxiolytic effects of CBD had been extensively demonstrated in animal studies and in healthy volunteers submitted to anxiety induced by several procedures, including the simulation of public speaking (Crippa et al, 2010, 2011). However, there is only one published report of the anxiolytic effect of CBD in an anxiety disorder (Crippa et al, 2010, 2011). This study was performed with SAD patients and the anxiolyic effects of CBD were detected before provoking anxiety by the tracer injection and scanning procedure of SPECT, suggesting that CBD facilitates habituation of anticipatory anxiety. The SPECT analysis of this study and of a previous one with healthy volunteers (Crippa et al, 2004) showed that the CBD effects were associated with the activity of the parahippocampal gyrus and hippocampus. Functional magnetic resonance imaging (fMRI) detected attenuated responses in the amygdala and in the cingulated cortex induced by CBD (600 mg) during the viewing of fearful facial stimuli (Fusar-Poli et al, 2009a). Moreover, CBD has shown to disrupt forward intrinsic connectivity between the amygdala and the anterior cingulate during the neural response to fearful faces (Fusar-Poli et al, 2009b). Taken together, these studies demonstrate the action of CBD in limbic and paralimbic brain areas, which are known to be associated with anxiety.
The anxiolytic action of CBD may be mediated by 5-HT1A receptors, as it displaces the agonist [3H]8-OHDPAT from the cloned human 5-HT1A receptor in a concentration-dependent manner and exerts an effect as an agonist at the human 5-HT1A receptor in signal-transduction studies (Russo et al, 2005). Additionally, CBD injected into the dorsolateral periaqueductal gray of rats produced anxiolytic-like effects in the elevated plus-maze and elevated T-maze, and these effects were prevented by a 5HT1A receptor antagonist (Soares et al, 2010; Campos and Guimaraes, 2008).
Another important observation of this study was that the increase of negative self-evaluation during public speaking was almost abolished by CBD. In a previous study, we suggested that the negative self-evaluation during the phobic situation of public speaking would be important for the avoidance and impairment in social functioning that support the diagnosis of SAD (Freitas-Ferrari et al, submitted). In that way, the observed effect of CBD for improving the self-evaluation during public speaking, which is one of the pivotal aspects of SAD, will influence the therapy of SAD patients.”
This shows that using CBD, performance was little changed from normal compared to those using placebo, especially immediately before, during, and soon after performing:
This shows CBD reduced anxiety and discomfort, improved cognitive impairment (mental functioning), and people felt more calm:
Click here for the study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/